← Alle mensen

EN

E N Gal-Yam

2 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Lasofoxifene versus fulvestrant bij ESR1-gemuteerd ER-positief mammacarcinoom: ELAINE 2 fase II

Annals of oncology : official journal of the European Society for Medical Oncology · 2023-12

Neratinib plus fulvestrant plus trastuzumab bij HR+/HER2-mutant mammacarcinoom

Annals of oncology : official journal of the European Society for Medical Oncology · 2023-10